| Filed On | Filing |
|---|---|
| 19 Aug 2024 |
Form 3/A: Pletcher Brett A, EVP, Chief Legal Officer
No securities owned |
| 06 Jul 2021 |
Form 3/A: Wysenski Nancy, Director
No securities owned |
| 27 Feb 2009 |
Form 3/A: Henderson John T, Director
Holds 1,500 shares of Common Stock |
| 29 Oct 2004 | Form 3/A: Dow Stephen M, Director and 7 others |
| 29 Oct 2004 | Form 3/A: Srb Associates Vi Lp, 10% owner |
| 29 Oct 2004 | Form 3/A: Sevin Rosen Fund Vi Lp, 10% owner |
| 27 Jul 2004 | Form 3/A: Trautman Jay K, Vice President, Technology |
| 27 Jul 2004 | Form 3/A: Spudich James A, Director |
| 27 Jul 2004 | Form 3/A: Sheridan Gail A, VP, Human Resources |
| 27 Jul 2004 | Form 3/A: Sabry James H, Director |
| 27 Jul 2004 | Form 3/A: Rutter William J, Director |
| 27 Jul 2004 |
Form 3/A: Morgans David J Jr, Sr. VP, Drug Discovery & Tech.
Holds 17,500 shares of Common Stock |
| 27 Jul 2004 | Form 3/A: Homcy Charles J, Director |
| 27 Jul 2004 |
Form 3/A: Blum Robert I, VP, Finance and Bus Dev, CFO
Holds 87,500 shares of Common Stock |
Loading...